Cargando…

Combination of High-Dose Intravenous Immunoglobulins and Itraconozole in Treating Chronic Mycotic Demyelinating Optic Neuritis

Mycotic demyelinating optic neuritis is a neurological disorder of the visual system caused by mycotoxins released by indoor toxic molds. Although the health effect of indoor toxic mold on the population worldwide is now one of the “emerging diseases”, its involvement in chronic demyelinating optic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Campbell, Andrew W., Anyanwu, Ebere C., Vojdani, Aristo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	TheScientificWorldJOURNAL 2003
Materias:	Case Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5974607/ https://www.ncbi.nlm.nih.gov/pubmed/12920306 http://dx.doi.org/10.1100/tsw.2003.49

Ejemplares similares

Neurophysiological Effects of Chronic Indoor Environmental Toxic Mold Exposure on Children
por: Anyanwu, Ebere C., et al.
Publicado: (2003)

Intravenous Immunoglobulin in the Treatment of Adalimumab-associated Optic Neuritis
por: Uchio, Naohiro, et al.
Publicado: (2021)

Biochemical Changes in the Serum of Patients with Chronic Toxigenic Mold Exposures: A Risk Factor for Multiple Renal Dysfunctions
por: Anyanwu, Ebere, et al.
Publicado: (2003)

Intravenous immunoglobulin for inflammatory demyelinating polyneuropathy
por: Talaei, M., et al.
Publicado: (2021)

Recurrent Optic Neuritis as the Initial Symptom in Demyelinating Diseases
por: Falcão-Gonçalves, Alessandra Billi, et al.
Publicado: (2018)

Reaction of antibodies to Campylobacter jejuni and cytolethal distending toxin B with tissues and food antigens
por: Vojdani, Aristo, et al.
Publicado: (2019)

Experimental mouse model of optic neuritis with inflammatory demyelination produced by passive transfer of neuromyelitis optica-immunoglobulin G
por: Asavapanumas, Nithi, et al.
Publicado: (2014)

Intravenous immunoglobulin and intravenous methylprednisolone as optimal induction treatment in chronic inflammatory demyelinating polyradiculoneuropathy: protocol of an international, randomised, double-blind, placebo-controlled trial (OPTIC)
por: Bus, S. R. M., et al.
Publicado: (2021)

Bilateral optic neuritis related to chronic inflammatory demyelinating polyneuropathy
por: Lin, Kui-Yueh, et al.
Publicado: (2015)

Fluctuation of zonulin levels in blood vs stability of antibodies
por: Vojdani, Aristo, et al.
Publicado: (2017)

Predicting the Response to Intravenous Immunoglobulins in an Animal Model of Chronic Neuritis
por: Meyer zu Horste, Gerd, et al.
Publicado: (2016)

Overview of diet and autoimmune demyelinating optic neuritis: a narrative review
por: Plafker, Scott M., et al.
Publicado: (2023)

The clinical application of critical flicker fusion frequency in demyelinating optic neuritis
por: Fu, Junxia, et al.
Publicado: (2021)

Withdrawal of intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy
por: Adrichem, Max E., et al.
Publicado: (2022)

Parameters Associated with the Required Drug Dose of Intravenous Immunoglobulin in Stable Chronic Inflammatory Demyelinating Polyradiculoneuropathy
por: Feyen, Ludger, et al.
Publicado: (2023)

Chronic demyelination exacerbates neuroaxonal loss in patients with MS with unilateral optic neuritis
por: You, Yuyi, et al.
Publicado: (2020)

Tumefactive Demyelination Associated with Bilateral Optic Neuritis in Neuromyelitis Optica Spectrum Disorders
por: Verma, Rajesh, et al.
Publicado: (2019)

Working up a child with demyelinating optic neuritis: Striking a balance!
por: Sachdeva, Virender, et al.
Publicado: (2021)

Alternatives to intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyradiculoneuropathy
por: Castle, Dan, et al.
Publicado: (2019)

Possible Combined Central and Peripheral Demyelination Presenting as Optic Neuritis, Cervical Myelitis, and Demyelinating Polyneuropathy with Marked Nerve Hypertrophy
por: Tajima, Yasutaka, et al.
Publicado: (2018)

Different visual evoked potentials in neuromyelitis optica spectrum disorder-related optic neuritis and idiopathic demyelinating optic neuritis: a prospective longitudinal analysis
por: Zheng, Cong, et al.
Publicado: (2022)

PReS-FINAL-2027: Cerebral demyelination and optic neuritis during treatment with eternacept and methotrexate
por: Christensen, AE, et al.
Publicado: (2013)

Relationship between Cerebrospinal Fluid Biomarkers for Inflammation, Demyelination and Neurodegeneration in Acute Optic Neuritis
por: Modvig, Signe, et al.
Publicado: (2013)

Overview of the pathogenesis and treatment of chronic inflammatory demyelinating polyneuropathy with intravenous immunoglobulins
por: Mahdi-Rogers, Mohamed, et al.
Publicado: (2010)

Genetic biomarkers for intravenous immunoglobulin response in chronic inflammatory demyelinating polyradiculoneuropathy
por: Kuitwaard, Krista, et al.
Publicado: (2021)

Ipsilateral Uveitis and Optic Neuritis in Multiple Sclerosis
por: Thouvenot, Eric, et al.
Publicado: (2012)

Intravenous immunoglobulin for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy: a systematic review and meta-analysis
por: Gaebel, Kathryn, et al.
Publicado: (2010)

The Correlation between Aquaporin-4 Antibody and the Visual Function of Patients with Demyelinating Optic Neuritis at Onset
por: Yang, Hui, et al.
Publicado: (2015)

Vascular hypoperfusion in acute optic neuritis is a potentially new neurovascular model for demyelinating diseases
por: Chen, Ta-Ching, et al.
Publicado: (2017)

Substantial Improvement in a Nerve Conduction Study of Lymphoma-associated Demyelinating Neuropathy Treated by Intravenous Immunoglobulin and Chemotherapy
por: Iemura, Tomoki, et al.
Publicado: (2018)

Catastrophic Embolism Following Cosmetic Injection of Autologous Fat: Are Silicone-Treated Syringes the Only Suspects on the Crime Scene?
por: Vojdani, Aristo, et al.
Publicado: (2022)

Effectiveness of intravenous immunoglobulin alone and intravenous immunoglobulin combined with high-dose aspirin in the acute stage of Kawasaki disease: study protocol for a randomized controlled trial
por: Kuo, Ho-Chang, et al.
Publicado: (2018)

Intravenous immunoglobulin G therapy for neonatal hyperbilirubinemia
por: Rasiah, Saisujani, et al.
Publicado: (2023)

Comparison of the Structure and Function of the Retina and the Optic Nerve in Patients with a History of Multiple Sclerosis-Related Demyelinating Retrobulbar Optic Neuritis Treated and Not Treated with Systemic Steroid Therapy
por: Nowacka, Barbara, et al.
Publicado: (2021)

A Case of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Optic Neuritis Responsive to Intravenous Immunoglobulin (IVIG) Therapy in a Pediatric Patient
por: Kadam, Rochita, et al.
Publicado: (2023)

Severe Chronic Inflammatory Demyelinating Polyneuropathy Ameliorated following High-dose (3 g/kg) Intravenous Immunoglobulin Therapy
por: Seino, Yusuke, et al.
Publicado: (2018)

Amyloid-Beta 1-42 Cross-Reactive Antibody Prevalent in Human Sera May Contribute to Intraneuronal Deposition of A-Beta-P-42
por: Vojdani, Aristo, et al.
Publicado: (2018)

The Role of Exposomes in the Pathophysiology of Autoimmune Diseases I: Toxic Chemicals and Food
por: Vojdani, Aristo, et al.
Publicado: (2021)

Bilateral optic neuritis with spine demyelination associated with influenza A H1N1 infection
por: Ambika, Selvakumar, et al.
Publicado: (2020)

Combined intravenous immunoglobulin and methylprednisolone as induction treatment in chronic inflammatory demyelinating polyneuropathy (OPTIC protocol): a prospective pilot study
por: Adrichem, M. E., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_n3hdahtkopmqj60el79brbo3ua